BioCentury
ARTICLE | Clinical News

Lomucin: Phase II

October 20, 2003 7:00 AM UTC

In a double-blind Irish Phase II trial in 55 patients, Lomucin improved FEV1 and FVC from baseline. Lomucin patients had a 0.04 liter improvement in FEV1 after 4 weeks, the primary endpoint, while pla...